-transparent.png){kind=logo}
The pharmacokinetics of PTT-119, a new alkylating agent, was studied in 8 advanced cancer patients. PTT-119 disappeared rapidly from plasma after administration at a dose of 3 mg/kg by i.v. bolus injection. The HPLC method shows plasma levels of m-bis (dichloroethyl)amino-phenyl-L-alanine which is the major metabolite of PPT-119. Elimination of the drug from plasma can be described by a one-compartment model. Mean values of 77.8 min for the half-life, 510.8 ml/min for the total plasma clearance and 0.69 l/kg for the volume of distribution were found.
Related Publications
F Pannuti, and
G Coppi, and
F Borella, and
A Martoni, and
L Urbano, and
B Melotti
October 1987,
Il Farmaco; edizione pratica,
F Pannuti, and
G Coppi, and
F Borella, and
A Martoni, and
L Urbano, and
B Melotti
January 1985,
Giornale italiano di chemioterapia,
F Pannuti, and
G Coppi, and
F Borella, and
A Martoni, and
L Urbano, and
B Melotti
January 1985,
Pharmacology,
F Pannuti, and
G Coppi, and
F Borella, and
A Martoni, and
L Urbano, and
B Melotti
January 1988,
Haematologica,
F Pannuti, and
G Coppi, and
F Borella, and
A Martoni, and
L Urbano, and
B Melotti
January 1990,
Cancer communications,
F Pannuti, and
G Coppi, and
F Borella, and
A Martoni, and
L Urbano, and
B Melotti
January 1989,
Cancer chemotherapy and pharmacology,
F Pannuti, and
G Coppi, and
F Borella, and
A Martoni, and
L Urbano, and
B Melotti
January 1987,
Immunopharmacology and immunotoxicology,
F Pannuti, and
G Coppi, and
F Borella, and
A Martoni, and
L Urbano, and
B Melotti
March 1990,
Blut,
F Pannuti, and
G Coppi, and
F Borella, and
A Martoni, and
L Urbano, and
B Melotti
January 1988,
Chemotherapy,
F Pannuti, and
G Coppi, and
F Borella, and
A Martoni, and
L Urbano, and
B Melotti
May 1990,
Blut,
